Annual Drug Patent Expirations for CLARINEX
Clarinex is a drug marketed by Merck Sharp Dohme and is included in five NDAs. It is available from two suppliers. There are four patents protecting this drug and four Paragraph IV challenges.
The generic ingredient in CLARINEX is desloratadine; pseudoephedrine sulfate. Two suppliers are listed for this compound. Additional details are available on the desloratadine; pseudoephedrine sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
